换一批
换一批Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma.
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);顺铂(Cisplatin);环磷酰胺(Cyclophosphamide);脱氧胞苷(Deoxycytidine);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);抗药性, 肿瘤(Drug Resistance, Neoplasm);上皮细胞(Epithelial Cells);女(雌)性(Female);人类(Humans);输注, 静脉内(Infusions, Intravenous);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);紫杉酚(Paclitaxel);聚乙烯二醇类(Polyethylene Glycols)
DOI
10.1016/j.ygyno.2007.08.061
PMID
17915300
发布时间
2022-12-07
- 浏览10
Gynecologic oncology
47-52页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
